Age-dependent effects of topiramate on the acquisition and the retention of rapid kindling

Epilepsia

Volumn 48, Issue 4, 2007, Pages 765-773

  Mazarati, Andréy ^a   Shin, Don ^a   Auvin, Stéphane ^a,b,c   Sankar, Raman ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antiepileptic drugs; Development; Epileptogenesis; Kindling; Temporal lobe epilepsy; Topiramate

Indexed keywords

TOPIRAMATE;

AFTERDISCHARGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROGRAPHY; KINDLING; LONG TERM MEMORY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTION POTENTIALS; AGE FACTORS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVOKED POTENTIALS, MOTOR; FRUCTOSE; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; NEURAL CONDUCTION; NEURONS; RATS; RATS, WISTAR; SEIZURES; TIME FACTORS; VEHICLES;

EID: 34247145935     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.00987.x     Document Type: Article

References (45)

1. Albright PS, Burnham WM. (1980) Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 21:681-689.
2. Amano K, Hamada K, Yagi K, Seino M. (1998) Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Research 31:123-128.
3. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. The Proceedings of the National Academy of Sciences, USA 99:15089-15094.
4. Cha BH, Silveira DC, Liu X, Hu Y, Holmes GL. (2002) Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Research 51:217-232.
5. Cilio MR, Sogawa Y, Cha BH, Liu X, Huang LT, Holmes GL. (2003) Long-term effects of status epilepticus in the immature brain are specific for age and model. Epilepsia 44:518-528.
6. De Smedt T, Vonck K, Raedt R, Dedeurwaerdere S, Claeys P, Legros B, Wyckhuys T, Wadman W, Boon P. (2005) Rapid kindling in preclinical anti-epileptic drug development: the effect of levetiracetam. Epilepsy Research 67:109-116.
7. Edwards HE, Burnham WM, MacLusky NJ. (1999) Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Research 838:151-157.
8. Glauser TA. (1997) Topiramate. Seminars in Pediatric Neurology 4:34-42.
9. Glauser TA. (1998) Topiramate use in pediatric patients. The Canadian Journal of Neurological Sciences 25:S8-S12.
10. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. (2004) Therapeutic doses of topiramate are not toxic to the developing rat brain. Experimental Neurology 187:403-409.
11. Holmes GL, Thompson JL. (1987) Rapid kindling in the prepubescent rat. Brain Research 433:281-284.
12. Klitgaard H. (2001) Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42(suppl. 4):13-18.
13. Koh S, Jensen FE. (2001) Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Annals of Neurology 50:366-372.
14. Koh S, Tibayan FD, Simpson JN, Jensen FE. (2004) NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45:569-575.
15. Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. The New England Journal of Medicine 342:314-319.
16. Lado FA, Sperber EF, Moshé SL. (2001) Anticonvulsant efficacy of gabapentin on kindling in the immature brain. Epilepsia 42:458-463.
17. Löscher W. (2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Research 50:105-123.
18. Löscher W, Honack D. (1990) The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats. Epilepsy Research 7:182-196.
19. Lothman EW, Hatlelid JM, Zorumski CF, Conry JA, Moon PF, JBP. (1985) Kindling with rapidly recurring hippocampal seizures. Brain Research 360:83-91.
20. Lothman EW, Williamson JM. (1992) Influence of electrical stimulus parameters on afterdischarge thresholds in the rat hippocampus. Epilepsy Research 13:205-213.
21. Lothman EW, Williamson JM. (1993) Rapid kindling with recurrent hippocampal seizures. Epilepsy Research 14:209-220.
22. Lothman EW, Williamson JM. (1994) Closely spaced recurrent hippocampal seizures elicit two types of heightened epileptogenesis: a rapidly developing, transient kindling and a slowly developing, enduring kindling. Brain Research 649:71-84.
23. McNamara JO, Rigsbee LC, Butler LS, Shin C. (1989) Intravenous phenytoin is an effective anticonvulsant in the kindling model. Annals of Neurology 26:675-678.
24. Michelson HB, Lothman EW. (1991) An ontogenetic study of kindling using rapidly recurring hippocampal seizures. Developmental Brain Research 61:79-85.
25. Morimoto K, Fahnestock M, Racine RJ. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Progress in Neurobiology 73:1-60.
26. Morrell MJ. (1992) Hormones and epilepsy through the lifetime. Epilepsia 33:S49-S61.
27. Moshé SL, Sharpless NS, Kaplan J. (1981) Kindling in developing rats: variability of afterdischarge thresholds with age. Brain Research 211:190-195.
28. Moshé SL, Sperber EF, Haas K, Xu S, Shinnar S. (1992) Effects of the maturational process on epileptogenesis. In Lüders H (Ed) Epilepsy surgery. Raven Press, New York, pp. 741-748.
29. Moshé SL, Stanton PK, Sperber EF. (1993) Sensitivity of the immature central nervous system to epileptogenic stimuli. In Schwartzkroin PA (Ed) Epilepsy: Models, mechanisms, and concepts. Cambridge University Press, Cambridge, pp. 171-198.
30. Pitkänen A, Sutula TP. (2002) Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. The Lancet Neurology 1:173-181.
31. Racine RJ. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalography and Clinical Neurophysiology 32:281-294.
32. Reissmuller E, Ebert U, Löscher W. (2000) Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats. Epilepsia 41:372-379.
33. Rho JM, Sankar R. (1999) The pharmacologic basis of antiepileptic drug action. Epilepsia 40:1471-1483.
34. Sankar R, Holmes GL. (2004) Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. Journal of Child Neurology 19(suppl. 1):S6-14.
35. Sankar R, Painter MJ. (2005) Neonatal seizures: after all these years we still love what doesn't work. Neurology 64:776-777.
36. Sankar R, Shin DH, Liu H, Mazarati A, Pereira de Vasconcelos A, Wasterlain CG. (1998) Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. Journal of Neuroscience 18:8382-8393.
37. Sankar R, Shin D, Mazarati AM, Liu H, Katsumori H, Lezama R, Wasterlain CG. (2000) Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity. Annals of Neurology 48:580-589.
38. Schmutz M, Klebs K, Baltzer V. (1988) Inhibition or enhancement of kindling evolution by antiepileptics. Journal of Neural Transmission 72:245-257.
39. Shank RP, Gardocki JF, Vaught JL, Davis CB, Schupsky JJ, Raffa RB, Dodgson SJ, Nortey SO, Maryanoff BE. (1994) Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia 35:450-460.
40. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Löscher W, Lowenstein DH, Moshe SL, Noebels JL, Davis M. (2002) Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 43:1410-1420.
41. Suchomelova L, Baldwin RA, Kubova H, Thompson KW, Sankar R, Wasterlain CG. (2006) Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatric Research 59:237-243.
42. Wauquier A, Zhou S. (1996) Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Research 24:73-77.
43. White HS. (2003) Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44(suppl. 7):2-8.
44. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Research 28:167-179.
45. Zhao Q, Hu Y, Holmes GL. (2005) Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy and Behavior 6:529-536.